Progress in pediatric cardiology VSI: Cardiovascular disease in pediatrics lipoprotein(a) in atherosclerotic cardiovascular disease, type 2 diabetes, and liver disease DOI Creative Commons
Kent A. Williams,

Molly Augustine,

Eru Sujakhu

et al.

Progress in Pediatric Cardiology, Journal Year: 2024, Volume and Issue: unknown, P. 101775 - 101775

Published: Dec. 1, 2024

Language: Английский

Waist to hip ratio modifies the cardiovascular risk of lipoprotein (a): Insights from MESA DOI Creative Commons
Muhammad Imtiaz Ahmad, Parag Anilkumar Chevli, Saeid Mirzai

et al.

Progress in Cardiovascular Diseases, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

1

The prevalence, patients' characteristics, and hyper-Lp(a)-emia risk factors in the polish population. The first results from the PMMHRI-Lp(a) registry DOI Creative Commons
Bożena Sosnowska, Joanna Lewek, Weronika Adach

et al.

Progress in Cardiovascular Diseases, Journal Year: 2024, Volume and Issue: 86, P. 54 - 61

Published: Aug. 25, 2024

The knowledge on the prevalence of elevated lipoprotein(a) (Lp(a)), patients' characteristics, and nongenetic risk factors is scarce in some regions including Poland, largest Central Eastern European country. Thus, we aimed to present results from Lp(a) registry established Poland's 2nd largest, supra-regional hospital - Polish Mother's Memorial Hospital Research Institute (PMMHRI).

Language: Английский

Citations

4

Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio DOI

Annalisa Filtz,

Martha Gulati

Progress in Cardiovascular Diseases, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0

Prevalence and role of elevated serum lipoprotein(a) in patients with myocardial infarction according to the Russian register of acute myocardial infarction REGION-MI DOI Open Access
М. В. Ежов, Р. М. Шахнович, И. А. Алексеева

et al.

Russian Cardiology Bulletin, Journal Year: 2025, Volume and Issue: 20(1), P. 39 - 39

Published: April 14, 2025

Objective. Serum lipoprotein(a) (Lp(a))>50 mg/dl is associated with higher risk of cardiovascular diseases and complications. The aim this study was to assess the prevalence elevated Lp(a) in patients acute myocardial infarction (MI) various regions Russian Federation (RF), as well target level low-density lipoprotein cholesterol (LDL cholesterol) these patients. Material methods. REGION–IM (Russian Registry Acute Myocardial Infarction) a multiple-center prospective observational study. follow-up included 3 stages: hospital-stay, 6 12 months after inclusion register. Demographic anamnestic data, information about MI were entered into registration card. analyzed 1.623 (22%) from 40 Federation. There 1.173 (72%) men 450 (28%) women aged 60 years (range 30—94). Results. Mean serum 12.4 2 — 722.2). This value significantly (15.5 versus 10.8 mg/dl, p<0.05) STEMI (12.9 p<0.05). >50 recorded 414 (26%) patients, 50—100 12.9%, 101—180 2.9%, > 180 10.3% Conclusion. 50 every fourth patient while extreme elevation (>180 mg/dl) tenth Screening at least once lifetime will allow determining category extremely high complications including those LDL-C.

Language: Английский

Citations

0

Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023 DOI Creative Commons

Ping Lai,

Shuquan Xu,

Ziyou Liu

et al.

Frontiers in Cardiovascular Medicine, Journal Year: 2024, Volume and Issue: 11

Published: Nov. 22, 2024

Background Following the identification of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, research in this area has experienced significant growth. However, a thorough bibliometric analysis burgeoning field remains conspicuously absent. The current study aims to delineate hotspots and anticipate future trends on PCSK9 inhibitors employing analysis. Methods A systematic search was conducted Web Science Core Collection (WoSCC) identify scholarly articles reviews pertaining yielding 1,812 documents. Data extraction followed by visualization using Excel, VOSviewer, CiteSpace software. Results total publications were included final Ray, KK from UK most prolific author, Pordy, R USA. USA led publication output [number (Np):776] number citations without self-citations (Nc) at 34,289, as well an H-index 93. “Cardiovascular System Cardiology” emerged predominant subject area. Amgen Journal Clinical Lipidology identified active institution journal, respectively. Keywords such “lipoprotein(a),” “bempedoic acid,” “percutaneous coronary intervention,” “inclisiran,” “peripheral artery disease,” “mortality,” “endothelial dysfunction” are gaining prominence field. Conclusion is experiencing sustained growth trajectory. exerts considerable influence area, with expected feature more groundbreaking studies. Research “lipoprotein(a)”, acid”, intervention”, disease”, poised become focal points investigation.

Language: Английский

Citations

0

Progress in pediatric cardiology VSI: Cardiovascular disease in pediatrics lipoprotein(a) in atherosclerotic cardiovascular disease, type 2 diabetes, and liver disease DOI Creative Commons
Kent A. Williams,

Molly Augustine,

Eru Sujakhu

et al.

Progress in Pediatric Cardiology, Journal Year: 2024, Volume and Issue: unknown, P. 101775 - 101775

Published: Dec. 1, 2024

Language: Английский

Citations

0